144 related articles for article (PubMed ID: 24705502)
1. Placotylene A, an inhibitor of the receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation, from a Korean sponge Placospongia sp.
Kim H; Kim KJ; Yeon JT; Kim SH; Won DH; Choi H; Nam SJ; Son YJ; Kang H
Mar Drugs; 2014 Apr; 12(4):2054-65. PubMed ID: 24705502
[TBL] [Abstract][Full Text] [Related]
2. Suppression of RANKL-Induced Osteoclastogenesis by the Metabolites from the Marine Fungus Aspergillus flocculosus Isolated from a Sponge Stylissa sp.
Shin HJ; Choi BK; Trinh PTH; Lee HS; Kang JS; Van TTT; Lee HS; Lee JS; Lee YJ; Lee J
Mar Drugs; 2018 Jan; 16(1):. PubMed ID: 29304006
[TBL] [Abstract][Full Text] [Related]
3. The Natural Product 6-Gingerol Inhibits Inflammation-Associated Osteoclast Differentiation via Reduction of Prostaglandin E₂ Levels.
Hwang YH; Kim T; Kim R; Ha H
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30013004
[TBL] [Abstract][Full Text] [Related]
4. Five Easy Pieces. The Total Synthesis of Phosphoiodyn A (and Placotylene A).
Galler DJ; Parker KA
Org Lett; 2015 Nov; 17(22):5544-6. PubMed ID: 26509219
[TBL] [Abstract][Full Text] [Related]
5. Haliclonyne, a new highly oxygenated polyacetylene from the marine sponge Haliclona species.
Chill L; Miroz A; Kashman Y
J Nat Prod; 2000 Apr; 63(4):523-6. PubMed ID: 10785431
[TBL] [Abstract][Full Text] [Related]
6. Chlorogenic acid inhibits osteoclast differentiation and bone resorption by down-regulation of receptor activator of nuclear factor kappa-B ligand-induced nuclear factor of activated T cells c1 expression.
Kwak SC; Lee C; Kim JY; Oh HM; So HS; Lee MS; Rho MC; Oh J
Biol Pharm Bull; 2013; 36(11):1779-86. PubMed ID: 23985829
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
8. Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression.
Hwang YH; Kim T; Kim R; Ha H
Molecules; 2018 Jul; 23(7):. PubMed ID: 30004401
[TBL] [Abstract][Full Text] [Related]
9. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
10. Amakusamine from a
Maeyama Y; Nakashima Y; Kato H; Hitora Y; Maki K; Inada N; Murakami S; Inazumi T; Ise Y; Sugimoto Y; Ishikawa H; Tsukamoto S
J Nat Prod; 2021 Oct; 84(10):2738-2743. PubMed ID: 34612636
[TBL] [Abstract][Full Text] [Related]
11. Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation.
Regmi A; Fuson T; Yang X; Kays J; Moxham C; Zartler E; Chandrashekhar S; Galvin RJ
Bone; 2005 Feb; 36(2):284-91. PubMed ID: 15780954
[TBL] [Abstract][Full Text] [Related]
12. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation.
Kim JA; Ihn HJ; Park JY; Lim J; Hong JM; Kim SH; Kim SY; Shin HI; Park EK
Int Orthop; 2015 Jan; 39(1):173-82. PubMed ID: 25416122
[TBL] [Abstract][Full Text] [Related]
14. Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages.
Kim AR; Kim HS; Lee JM; Choi JH; Kim SN; Kim DK; Kim JH; Mun SH; Kim JW; Jeon HS; Kim YM; Choi WS
Eur J Pharmacol; 2012 May; 682(1-3):29-36. PubMed ID: 22387094
[TBL] [Abstract][Full Text] [Related]
15. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
Shim KS; Ma CJ; Kim DS; Ma JY
J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
[TBL] [Abstract][Full Text] [Related]
16. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.
Lee JW; Iwahashi A; Hasegawa S; Yonezawa T; Jeon WB; Cha BY; Nagai K; Woo JT
J Nat Med; 2012 Jan; 66(1):8-16. PubMed ID: 21656335
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
18. Novel diether compounds inhibiting differentiation of osteoclasts.
Doh KE; Kang JH; Ting Z; Yim M; Choo HP
Arch Pharm Res; 2016 Feb; 39(2):178-190. PubMed ID: 26670177
[TBL] [Abstract][Full Text] [Related]
19. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
20. Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts.
Kato H; Kai A; Kawabata T; Sunderhaus JD; McAfoos TJ; Finefield JM; Sugimoto Y; Williams RM; Tsukamoto S
Bioorg Med Chem Lett; 2017 Nov; 27(22):4975-4978. PubMed ID: 29037945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
